The U.S. Food and Drug Administration (FDA) voted in support of the benefit-risk profile of Lumisight (pegulicianine), an imaging enhancement agent used with the Lumicell fluorescent-guided imaging system.
Read More
The U.S. Food and Drug Administration (FDA) voted in support of the benefit-risk profile of Lumisight (pegulicianine), an imaging enhancement agent used with the Lumicell fluorescent-guided imaging system.
Read More
LET US PROVIDE YOU WITH THE LATEST MEDICAL NEWS, NETWORKING AND PROFESSIONAL DEVELOPMENT OPPORTUNITIES, AND EXCITING JOB OPENINGS FOR RADIOLOGISTS.
"*" indicates required fields
